The Major Depressive Disorder Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Major Depressive Disorder Market?
The Major Depressive Disorder Global Market Report 2025 shows that the market size has been experiencing stable growth. It increased from $6.12 billion in 2024 to $6.28 billion in 2025, with a compound annual growth rate (CAGR) of 2.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Major Depressive Disorder Industry?
The Major Depressive Disorder Global Market is projected to reach a value of $7.13 billion in 2029, expanding at a compound annual growth rate (CAGR) of 3.2%.
Download Your Free Sample of the 2025 Major Depressive Disorder Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Major Depressive Disorder Market?
The key drivers in the major depressive disorder market are:
• The development and application of precision medicine
• The advancement and use of telepsychiatry and teletherapy
• The introduction of novel treatment modalities
• The global expansion and accessibility of mental health services
Global Market Segmentation: Identifying Major Major Depressive Disorder Industry Segments
The major depressive disorder market covered in this report is segmented –
1) By Treatment: Psychotherapy, Medications, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Other Treatments
2) By Diagnosis: Physical Examinations, Laboratory Tests, Psychiatric Evaluations, Diagnostic And Statistical Manual of Mental Disorders (DSM-
5), Other Diagnosis
3) By End-User: Clinics, Hospitals, Other End-Users
Pre-order the 2025 Major Depressive Disorder Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Major Depressive Disorder Market?
The key trends in the major depressive disorder market are:
• Precision medicine is beginning to play a significant role in the development of the market.
• The growth of telepsychiatry and teletherapy solutions is dictating the future of the depression disorder market.
• The introduction of novel treatment modalities is a major emerging trend.
• The global expansion of mental health services is directly impacting the market.
Who Are the Top Competitors & Leading Players in the Major Depressive Disorder Market?
Major companies in the major depressive disorder market are:
• Pfizer Inc.
• Janssen Research And Development LLC
• Merck and Co. Inc.
• Novartis AG
• Sanofi-Aventis US LLC
• Bristol Myers Squibb Co.
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Biogen Inc.
• Otsuka Pharmaceuticals Co.Ltd.
• Forest Laboratories Inc.
• H. Lundbeck A/S
• Richter Gedeon PLC
• Allergan PLC
• Neurocrine Biosciences Inc.
• BlackThorn Therapeutics Inc.
• Intra-Cellular Therapies Inc.
• Axsome Therapeutics Inc.
• Luye Pharma Group
• BioLite Inc.
• BrainsWay Ltd.
• Neumora Therapeutics Inc.
• Chase Therapeutics Corporation
• SAGE Therapeutics Inc.
• Arrivo Bioventures LLC
• Relmada Therapeutics Inc.
• Fabre-Kramer Pharmaceuticals Inc.
• Vistagen Therapeutics Inc.
Regional Dominance: Which Area Leads the Global Major Depressive Disorder Market?
North America was the largest region in the major depressive disorder market in 2024
